← Evidence map

ReviewIJID regions2025

Possible reluctance to shorten antibiotic duration in Gram-negative bacteremia and limitations of mortality-based outcomes: the need to prioritize clinical-microbiologic recurrence in future trials-Insights from the "Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness" (BALANCE) Trial.

Samadhi PatamatamkulPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40236921